16S rRNA gene mutations associated with decreased susceptibility to tetracycline in Mycoplasma bovis

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 2, 2015, Pages 796-802

  Amram, E ^a,b   Mikula, I ^a   Schnee, C ^c   Ayling, R D ^d   Nicholas, R A J ^d   Rosales, R S ^d   Harrus, S ^b   Lysnyanskya, I ^a  

^a KIMRON VETERINARY INSTITUTE   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^d VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CYSTEINE; GLYCINE; RNA 16S; TETRACYCLINE; THREONINE; ANTIINFECTIVE AGENT;

ALLELE; ALPHA HELIX; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENOME; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; BINDING SITE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BINDING; ESCHERICHIA COLI; GENE EXPRESSION; GENE MUTATION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA BOVIS; PRIORITY JOURNAL; DNA SEQUENCE; DRUG EFFECTS; GENETICS; MICROBIAL SENSITIVITY TEST; MUTATION;

ANTI-BACTERIAL AGENTS; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOPLASMA BOVIS; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; TETRACYCLINE; TETRACYCLINE RESISTANCE;

EID: 84921777404     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.03876-14     Document Type: Article

References (41)

1. Nicholas RA, Ayling RD. 2003. Mycoplasma bovis: disease, diagnosis, and control. Res Vet Sci 74:105-112. http://dx.doi.org/10.1016/S0034 -5288(02)00155-8.
2. Giguere S. 2007. Tetracyclines and glycylcyclines, p 231-240. In Giguere S, Prescott JF, Baggot JD, Walker RD, Dowling PM (ed), Antimicrobial therapy in veterinary medicine, 4th ed. Wiley Blackwell, Hoboken, NJ.
3. Brysker A (ed). 2005. Antimicrobial agents: antibacterials and antifungals. ASM Press, Washington, DC.
4. Chopra I, Roberts M. 2001. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev 65:232-260. http://dx.doi.org/10.1128/MMBR.65 .2.232-260.2001.
5. Roberts MC, Koutsky LA, Holmes KK, LeBlanc DJ, Kenny GE. 1985. Tetracycline-resistant Mycoplasma hominis strains contain streptococcal tetM sequences. Antimicrob Agents Chemother 28:141-143. http://dx.doi .org/10.1128/AAC.28.1.141.
6. Roberts MC, Hillier SL, Hale J, Holmes KK, Kenny GE. 1986. Tetracycline resistance and tetM in pathogenic urogenital bacteria. Antimicrob Agents Chemother 30: 810-812. http://dx.doi.org/10.1128 /AAC.30.5.810.
7. Degrange S, Renaudin H, Charron A, Pereyre S, Bebear C, Bebear CM. 2008. Reduced susceptibility to tetracyclines is associated in vitro with the presence of 16S rRNA mutations in Mycoplasma hominis and Mycoplasma pneumoniae. J Antimicrob Chemother 61:1390-1392. http://dx.doi.org /10.1093/jac/dkn118.
8. Waites KB, Lysnyansky I, Bébéar CM. 2014. Emerging antimicrobial resistance in mycoplasmas of humans and animals, p 289-322. In Browning GF, Citti C (ed), Mollicutes: molecular biology and pathogenesis. Caister Academic Press, Poole, United Kingdom.
9. Ayling RD, Baker SE, Peek ML, Simon AJ, Nicholas RA. 2000. Comparison of in vitro activity of danofloxacin, florfenicol, oxytetracycline, spectinomycin and tilmicosin against recent field isolates of Mycoplasma bovis. Vet Rec 146:745-747. http://dx.doi.org/10.1136/vr.146.26.745.
10. Thomas A, Nicolas C, Dizier I, Mainil J, Linden A. 2003. Antibiotic susceptibilities of recent isolates of Mycoplasma bovis in Belgium. Vet Rec 153:428-431. http://dx.doi.org/10.1136/vr.153.14.428.
11. Rosenbusch RF, Kinyon JM, Apley M, Funk ND, Smith SC, Hoffman LJ. 2005. In vitro antimicrobial inhibition profiles of Mycoplasma bovis isolates recovered from various regions of the United States from 2002 to 2003. J Vet Diagn Invest 17: 436-441. http://dx.doi.org/10.1177 /104063870501700505.
12. Gautier-Bouchardon AV, Ferre S, Le Grand D, Paoli A, Gay E, Poumarat F. 2014. Overall decrease in the susceptibility of Mycoplasma bovis to antimicrobials over the past 30 years in France. PLoS One 9:e87672. http://dx.doi.org/10.1371/journal.pone.0087672.
13. Uemura R, Sueyoshi M, Nagatomo H. 2010. Antimicrobial susceptibilities of four species of mycoplasma isolated in 2008 and 2009 from cattle in Japan. J Vet Med Sci 72:1661-1663. http://dx.doi.org/10.1292/jvms.10 -0165.
14. Francoz D, Fortin M, Fecteau G, Messier S. 2005. Determination of Mycoplasma bovis susceptibilities against six antimicrobial agents using the E test method. Vet Microbiol 105:57-64. http://dx.doi.org/10.1016/j .vetmic.2004.10.006.
15. Soehnlen MK, Kunze ME, Karunathilake KE, Henwood BM, Kariyawasam S, Wolfgang DR, Jayarao BM. 2011. In vitro antimicrobial inhibition of Mycoplasma bovis isolates submitted to the Pennsylvania Animal Diagnostic Laboratory using flow cytometry and a broth microdilution method. J Vet Diagn Invest 23:547-551. http://dx.doi.org/10.1177 /1040638711404155.
16. Wise KS, Calcutt MJ, Foecking MF, Roske K, Madupu R, Methe BA. 2011. Complete genome sequence of Mycoplasma bovis type strain PG45 (ATCC 25523). Infect Immun 79:982-983. http://dx.doi.org/10.1128/IAI .00726-10.
17. Li Y, Zheng H, Liu Y, Jiang Y, Xin J, Chen W, Song Z. 2011. The complete genome sequence of Mycoplasma bovis strain Hubei-1. PLoS One 6:e20999. http://dx.doi.org/10.1371/journal.pone.0020999.
18. Qi J, Guo A, Cui P, Chen Y, Mustafa R, Ba X, Hu C, Bai Z, Chen X, Shi L, Chen H. 2012. Comparative geno-plasticity analysis of Mycoplasma bovis HB0801 (Chinese isolate). PLoS One 7:e38239. http://dx.doi.org/10 .1371/journal.pone.0038239.
19. Rosengarten R, Behrens A, Stetefeld A, Heller M, Ahrens M, Sachse K, Yogev D, Kirchhoff H. 1994. Antigen heterogeneity among isolates of Mycoplasma bovis is generated by high-frequency variation of diverse membrane surface proteins. Infect Immun 62:5066-5074.
20. Hannan PC, Windsor GD, de Jong A, Schmeer N, Stegemann M. 1997. Comparative susceptibilities of various animal-pathogenic mycoplasmas to fluoroquinolones. Antimicrob Agents Chemother 41:2037-2040.
21. Waites KB, Duffy LB, Bebear CM, Matlow A, Talkington DF, Kenny GE, Totten PA, Bade DJ, Zheng X, Davidson MK, Shortridge VD, Watts JL, Brown SD. 2012. Standardized methods and quality control limits for agar and broth microdilution susceptibility testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum. J Clin Microbiol 50:3542-3547. http://dx.doi.org/10.1128/JCM.01439-12.
22. Gerchman I, Levisohn S, Mikula I, Lysnyansky I. 2009. In vitro antimicrobial susceptibility of Mycoplasma bovis isolated in Israel from local and imported cattle. Vet Microbiol 137:268-275. http://dx.doi.org/10.1016/j .vetmic.2009.01.028.
23. Hall TA. 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 41:95-98.
24. Aminov RI, Garrigues-Jeanjean N, Mackie RI. 2001. Molecular ecology of tetracycline resistance: development and validation of primers for detection of tetracycline resistance genes encoding ribosomal protection proteins. Appl Environ Microbiol 67:22-32. http://dx.doi.org/10.1128 /AEM.67.1.22-32.2001.
25. Nishimoto Y, Kobayashi N, Alam MM, Ishino M, Uehara N, Watanabe N. 2005. Analysis of the prevalence of tetracycline resistance genes in clinical isolates of Enterococcus faecalis and Enterococcus faecium in a Japanese hospital. Microb Drug Resist 11:146-153. http://dx.doi.org/10.1089 /mdr.2005.11.146.
26. Trzcinski K, Cooper BS, Hryniewicz W, Dowson CG. 2000. Expression of resistance to tetracyclines in strains of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 45:763-770. http://dx.doi.org/10 .1093/jac/45.6.763.
27. Lysnyansky I, Yogev D, Levisohn S. 2008. Molecular characterization of the Mycoplasma bovis p68 gene, encoding a basic membrane protein with homology to P48 of Mycoplasma agalactiae. FEMS Microbiol Lett 279: 234-242. http://dx.doi.org/10.1111/j.1574-6968.2007.01040.x.
28. Blanchard A, Crabb DM, Dybvig K, Duffy LB, Cassell GH. 1992. Rapid detection of tetM in Mycoplasma hominis and Ureaplasma urealyticum by PCR: tetM confers resistance to tetracycline but not necessarily to doxycycline. FEMS Microbiol Lett 74:277-281.
29. Pioletti M, Schlunzen F, Harms J, Zarivach R, Gluhmann M, Avila H, Bashan A, Bartels H, Auerbach T, Jacobi C, Hartsch T, Yonath A, Franceschi F. 2001. Crystal structures of complexes of the small ribosomal subunit with tetracycline, edeine and IF3. EMBO J 20:1829-1839. http: //dx.doi.org/10.1093/emboj/20.8.1829.
30. Brodersen DE, Clemons WM, Jr, Carter AP, Morgan-Warren RJ, Wimberly BT, Ramakrishnan V. 2000. The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit. Cell 103:1143-1154. http://dx.doi.org/10.1016/S0092 -8674(00)00216-6.
31. Dailidiene D, Bertoli MT, Miciuleviciene J, Mukhopadhyay AK, Dailide G, Pascasio MA, Kupcinskas L, Berg DE. 2002. Emergence of tetracycline resistance in Helicobacter pylori: multiple mutational changes in 16S ribosomal DNA and other genetic loci. Antimicrob Agents Chemother 46: 3940-3946. http://dx.doi.org/10.1128/AAC.46.12.3940-3946.2002.
32. Wu JY, Kim JJ, Reddy R, Wang WM, Graham DY, Kwon DH. 2005. Tetracycline-resistant clinical Helicobacter pylori isolates with and without mutations in 16S rRNA-encoding genes. Antimicrob Agents Chemother 49:578-583. http://dx.doi.org/10.1128/AAC.49.2.578-583.2005.
33. Trieber CA, Taylor DE. 2002. Mutations in the 16S rRNA genes of Helicobacter pylori mediate resistance to tetracycline. J Bacteriol 184:2131-2140. http://dx.doi.org/10.1128/JB.184.8.2131-2140.2002.
34. Gerrits MM, Berning M, Van Vliet AH, Kuipers EJ, Kusters JG. 2003. Effects of 16S rRNA gene mutations on tetracycline resistance in Helicobacter pylori. Antimicrob Agents Chemother 47:2984-2986. http://dx.doi .org/10.1128/AAC.47.9.2984-2986.2003.
35. Ross JI, Eady EA, Cove JH, Cunliffe WJ. 1998. 16S rRNA mutation associated with tetracycline resistance in a gram-positive bacterium. Antimicrob Agents Chemother 42:1702-1705.
36. Pringle M, Fellstrom C, Johansson KE. 2007. Decreased susceptibility to doxycycline associated with a 16S rRNA gene mutation in Brachyspira hyodysenteriae. Vet Microbiol 123:245-248. http://dx.doi.org/10.1016/j .vetmic.2007.02.019.
37. Verlinden M, Boyen F, Pasmans F, Garmyn A, Haesebrouck F, Martel A. 2011. Antimicrobial susceptibility pattern of Brachyspira intermedia isolates from European layers. Microb Drug Resist 17:485-488. http://dx .doi.org/10.1089/mdr.2011.0082.
38. Sigmund CD, Ettayebi M, Morgan EA. 1984. Antibiotic resistance mutations in 16S and 23S ribosomal RNA genes of Escherichia coli. Nucleic Acids Res 12:4653-4663. http://dx.doi.org/10.1093/nar/12.11.4653.
39. Makosky PC, Dahlberg AE. 1987. Spectinomycin resistance at site 1192 in 16S ribosomal RNA of E. coli: an analysis of three mutants. Biochimie 69:885-889. http://dx.doi.org/10.1016/0300-9084(87)90216-1.
40. Beeton ML, Chalker VJ, Maxwell NC, Kotecha S, Spiller OB. 2009. Concurrent titration and determination of antibiotic resistance in Ureaplasma species with identification of novel point mutations in genes associated with resistance. Antimicrob Agents Chemother 53:2020-2027. http://dx.doi.org/10.1128/AAC.01349-08.
41. Lerner U, Amram E, Ayling RD, Mikula I, Gerchman I, Harrus S, Teff D, Yogev D, Lysnyansky I. 2014. Acquired resistance to the 16-membered macrolides tylosin and tilmicosin by Mycoplasma bovis. Vet Microbiol 168:365-371. http://dx.doi.org/10.1016/j.vetmic.2013.11.033.